Losartan Potassium
Product Images NDC 64205-225

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 64205-225). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Readymeds, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
The available text seems to be a label or a clinical study graph for medication that contains Atenolol and Losartan Potassium. The graph displays the adjusted risk reduction percentage over a study period of 60 months. However, without additional context or information, it is not possible to provide a more informative description.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
This appears to be a table showing the primary composite stroke events within various demographic subgroups in a study comparing the effect of Losartan potassium tablets versus Atenolol on patients. The table includes the number of events, patient rates, and hazard ratios. The subgroups include age, gender, race, history of cardiovascular disease, and presence of diabetes. The table includes a note stating that it is adjusted for baseline Framingham risk score and level of electrocardiographic left ventricular hypotrophy. There is also a footnote explaining that "other" includes various ethnicities.*
FDA Label Image

Figure-4 (Figure 4)

Figure-4 (Figure 4)
This text provides a statistical analysis of the effectiveness of Losartan Potassium Tablets in reducing the risk of an unspecified event in patients. The analysis shows that a 16.1% risk reduction was achieved with the use of Losartan Potassium Tablets in comparison to a placebo. The p value was 0.02, indicating statistical significance. The time frame for the analysis was 12, 24, 36, and 48 months.*
FDA Label Image

Photo 1 (Photo 1)

Photo 1 (Photo 1)
This is a label of Losartan medication bottle which contains 30 tablets of 100mg strength. It also includes the NDC code (84205-226-30), expiration date, and lot number.*
FDA Label Image

Photo 2 (Photo 2)

Photo 2 (Photo 2)
This is a label description for a medication called Losartan, in the strength of 50mg and quantity of 30 tablets. It includes the NDC code (National Drug Code) and lot number, but the expiration date is missing.*
FDA Label Image

Structure-losartan Potassium (Structure)

Structure-losartan Potassium (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.